Manchester
Manchester ECMC aims to expand and develop its experimental cancer medicine portfolio in areas such as radiotherapy, proteomics, metabolomics and imaging. The Centre has an active early phase (phase I/II) clinical trial programme in various cancer types, with related biomarkers studies, which aim to inform treatment decisions and monitor the effectiveness of therapies.
Clinical Focus Area
- Medical Oncology [Early phase clinical trials]
- Radiotherapy
- Radioimmunology
- Academic surgery
Scientific Focus Area
- Biomarker development
- Angiogenesis
- Cell Death
- Metastasis
- DNA damage & repair
Disease Focus Area
| Leukaemia | Relevant to all types of cancer |
Goals
Skills
Manchester ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Manchester ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page